Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in BIOCRYST PHARMACEUTICALS INC
BNP PARIBAS FINANCIAL MARKETS holds 2.5M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $19.8M as of 2025-Q4. The position was increased (++21.4% shares). BCRX represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$19.8M
Current Shares
2.5M
Total Value Change
+$19.3M
Total Shares Change
+2.5M
Other major holders of BCRX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 2.5M |
+21.4% |
| $19.8M |
| 0.0% |
| $7.66 |
34 |
| 2025-Q3 | Increased | 2.1M | +43.8% | $15.9M | 0.0% | $7.55 | 38 |
| 2025-Q2 | Increased | 1.5M | +1059.7% | $13.1M | 0.0% | $9.36 | 45 |
| 2025-Q1 | Decreased | 125,627 | -36.0% | $942,202 | 0.0% | $7.86 | 0 |
| 2024-Q4 | Decreased | 196,225 | -60.5% | $1.5M | 0.0% | $7.53 | 0 |
| 2024-Q3 | Increased | 496,784 | +472.0% | $3.8M | 0.0% | $7.62 | 43 |
| 2024-Q2 | Decreased | 86,846 | -48.2% | $536,708 | 0.0% | $6.18 | 0 |